Next issueIssue 23 · Tue 17 Nov 

Trials

NCT07219173

Trial ID
T-ctgov-NCT07219173
Registry
ClinicalTrials.gov
NCT number
NCT07219173
Sponsor, as registered
Eli Lilly and Company
Phase
PHASE2
Indication
Asthma
Status
RECRUITING
Start date
2025-10-22
Primary completion
2028-04
Registered countries
Argentina, Brazil, Canada, China, France, Germany, India, Japan, Mexico, Netherlands, Poland, United States
Sites
120

The sponsor's registered location list, which states intent rather than approval.

clinicaltrials.govctgov registryverified 2026-11-07

Notes on the record

Supersedes the row verified 2026-10-26 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07219173); record last update posted 2026-11-05. site_count 119 to 120 location entries; status, dates and the twelve countries unchanged. Flagged by the collector (inbox/2026-11-06.json); collector proposal replaced by this live read.

Company

Through brenipatide (LY3537031): Lilly

Cited in

Issues quoting NCT07219173 in their own text.

Record history